Tyra Biosciences

IPO

Next-Generation Precision Medicines

Public · Carlsbad, United States · Founded 2019 · $156.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Website
tyra.bio
Total Funding
$156.0M
Last Round
$106.0M Series BMar 2021
Rounds
2
Type
Public

About

Tyra Biosciences is a clinical-stage biotechnology company developing next-generation precision medicines targeting FGFR biology and acquired resistance in oncology. Its proprietary SNÅP discovery platform enables rapid structural snapshots of drug-target interactions, accelerating structure-based drug design from weeks to days. The company has raised over $156M in financing to advance its oncology pipeline.

Summary

Tyra Biosciences is a Biotech company based in Carlsbad, United States, founded in 2019. It has raised $156.0M in total across 2 rounds, most recently a $106.0M Series B round in Mar 2021. Investors include Alta Partners, RA Capital Management and Canaan Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondary MarketJan 2024

Sign up to see all 4 rounds

Series A through Secondary Market — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Tyra Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/tyra-biosciences"><img src="https://indexed.vc/api/badge/company/tyra-biosciences" alt="Tyra Biosciences on Indexed.vc" width="260" height="76" /></a>